PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsMycophenolate sodium
Mycophenolate sodium
Download report
Favorite
Novartis Pharmaceuticals
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
1186 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Kidney transplantationD01603015444910325225
LeukemiaD007938C955815414221222
SyndromeD01357730816311117
Graft vs host diseaseD006086D89.811638126769
RecurrenceD012008194152361
NephritisD009393N051191791156
Lupus nephritisD008181EFO_00057611191791055
Renal insufficiencyD051437HP_0000083N19910715541
Liver transplantationD016031EFO_00106822131014441
Kidney diseasesD007674EFO_0003086N08461113940
Show 109 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Myelodysplastic syndromesD009190D4645119616167
LymphomaD008223C85.932109515146
Myeloid leukemia acuteD015470C92.03088119125
Myeloid leukemiaD007951C922885108119
PreleukemiaD0112893280311113
Multiple myelomaD009101C90.0246841297
Precursor cell lymphoblastic leukemia-lymphomaD05419823687897
Non-hodgkin lymphomaD008228C85.917645885
Bcr-abl positive chronic myelogenous leukemiaD015464EFO_000034014626579
Hematologic neoplasmsD01933724554674
Show 73 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Myelomonocytic leukemia juvenileD054429C93.31629240
Myelomonocytic leukemia chronicD015477C93.11525235
PlasmacytomaD010954C90.3723532
Primary myelofibrosisD055728D47.4718328
B-cell lymphomaD016393423428
B-cell lymphoma marginal zoneD018442C88.4322427
T-cell lymphomaD016399520426
Aplastic anemiaD000741HP_0001915D61.9420325
Myeloid leukemia accelerated phaseD015465513217
MycosesD009181B35-B49312417
Show 150 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MalnutritionD044342EFO_0008572E40-E46336
Islets of langerhans transplantationD016381123
GlioblastomaD005909EFO_000051522
AstrocytomaD001254EFO_000027122
Chronic granulomatous diseaseD006105EFO_0000338D71112
Brain neoplasmsD001932EFO_0003833C7111
GliomaD005910EFO_000052011
Germ cell and embryonal neoplasmsD00937311
MedulloblastomaD00852711
Rhabdoid tumorD01833511
Show 13 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ProteinuriaD011507HP_0000093R8022
InfertilityD007246HP_000078922
Uveomeningoencephalitic syndromeD014607Orphanet_3437H20.8222
Heart disease risk factorsD00008274211
Bone diseasesD001847M89.911
Antibody formationD00091711
Choroidal neovascularizationD02025611
Pathologic neovascularizationD00938911
ScleritisD015423HP_0100534H15.011
Lysosomal storage diseasesD01646411
Show 20 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 1,535 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
1,523 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use